Cooperation between STAT3 and c-Jun suppresses Fas transcription

Molecular Cell

Volumn 7, Issue 3, 2001, Pages 517-528

  Ivanov, Vladimir N ^a   Bhoumik, Anindita ^a   Krasilnikov, Mikhail ^a   Raz, Regina ^b   Owen Schaub, Laurie B ^c   Levy, David ^b   Horvath, Curt M ^a   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN C JUN; STAT3 PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; TUMOR GROWTH; ULTRAVIOLET IRRADIATION;

ANIMALIA;

EID: 0035265830     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00199-X     Document Type: Article

References (52)

1. Development of 3T3-like lines from Balb/c mouse embryo cultures: Transformation susceptibility to SV40
2. STATs in oncogenesis
3. The role of STATs in transcriptional control and their impact on cellular function
4. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma
5. Stat3 as an oncogene
6. Mechanism of action of a dominant-negative mutant of c-Jun
7. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription
8. STAT proteins as novel targets for cancer therapy. Signal transducers an activator of transcription
9. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
10. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
11. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment
12. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1
13. Malignant melanoma: Modern black plague and genetic black box
14. The orientation of the AP-1 heterodimer on DNA strongly affects transcriptional potency
15. STATs and gene regulation
16. Characterization of an interleukin 4 (IL-4) responsive region in immunoglobulin heavy chain germline epsilon promoter: Regular NF-IL-4, a C/EBP family member and NF-kappa B/p50
17. c-Jun inhibits transforming growth factor beta -mediated transcription by repressing smad3 transcriptional activity
18. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation
19. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
20. Constitutive activation on Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
21. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
22. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells
23. MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun
24. Fas-mediated apoptosis in tumor formation and defense
25. Cytokine receptor signalling
26. Down-regulation of tumor necrosis factor α expression by activating transcription factors 2 increases UVC-induced apoptosis of late-stage melanoma cells
27. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression
28. Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis
29. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
30. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes
31. Stat1 depends on transcriptionally synergy with Sp1
32. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
33. Prognostic relevance of altered Fas (CD95)-system in human breast cancer
34. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
35. Fas ligand-induced apoptosis
36. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
37. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRAC1 in differential regulation of IFN-gamma target genes
38. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
39. Fas and Fas ligand interactions suppress melanoma lung metastasis
40. DNA bending by Fos-Jun and the orientation of heterodimer binding depend on the sequence of the AP-1 site
41. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
42. Essential role of STAT3 for embryonic stem cell pluripotency
43. Molecular biology of human melanoma development and progression
44. Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3
45. Control of cell cycle progression by c-Jun is p53 dependent
46. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
47. Functional interactions between Stat5 and the glucocorticoid receptor
48. Modulation of growth and apoptosis response in PC-3 and LNCAP prostate cell lines by Fas
49. Hypoxia-induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardio-myocytes
50. Maximal activation of transcription of Stat1 and Stat3 requires both tyrosine and serine phosphorylation
51. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms
52. Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation